EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Neutralizing activity and T-cell response after bivalent fifth dose of messenger RNA vaccine in people living with HIV

Alessandra Vergori, Giulia Matusali, Alessandro Cozzi Lepri, Eleonora Cimini, Marisa Fusto, Francesca Colavita, Roberta Gagliardini, Stefania Notari, Valentina Mazzotta, Davide Mariotti, Stefania Cicalini, Enrico Girardi und 4 weitere

International Journal of Infectious Diseases · 2023

DOI: 10.1016/j.ijid.2023.06.010 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Infectious Diseases, 2023. Verfasst von Alessandra Vergori und 15 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Infectious Diseases Lazzaro Spallanzani, Scientific Hospital and Care Institutions, HIV/AIDS Unit, Rome, Italy. Electronic add…. Hauptthemen laut MEDLINE: Acquired Immunodeficiency Syndrome, COVID-19. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Administration for Community Living, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To investigate immunogenicity of SARS-CoV-2 vaccine third booster dose (3BD; fifth dose) with bivalent vaccine original/BA4/5 vaccine in people living with HIV (PLWH). METHODS: This is an observational cohort study to evaluate the outcomes of SARS-CoV-2 vaccination (HIV-VAC study). We analyzed microneutralization assay and interferon-γ production in 48 PLWH on antiretroviral therapy with clusters of differentiation (CD4) count

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acquired Immunodeficiency SyndromeCOVID-19HumansCOVID-19 VaccinesT-LymphocytesSARS-CoV-2Vaccines, SyntheticVaccines, CombinedAntibodies, NeutralizingAntibodies, ViralmRNA Vaccines

Stichwörter der Autor:innen

AIDSNeutralizing antibodiesOmicron sub-variantsT-specific cell immunitymRNA bivalent vaccine

Substanzen

COVID-19 VaccinesVaccines, SyntheticVaccines, CombinedAntibodies, NeutralizingAntibodies, ViralmRNA Vaccines

Autor:innen und Institutionen

  • National Institute for Infectious Diseases Lazzaro Spallanzani, Scientific Hospital and Care Institutions, HIV/AIDS Unit, Rome, Italy. Electronic address: alessandra.vergori@inmi.it.
  • National Institute for Infectious Diseases Lazzaro Spallanzani, Scientific Hospital and Care Institutions, Laboratory of Virology, Rome, Italy.
  • Institute for Global Health, University College of London, Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), London, UK.
  • National Institute for Infectious Diseases Lazzaro Spallanzani, Scientific Hospital and Care Institutions, Immunology Unit, Rome, Italy.
  • National Institute for Infectious Diseases Lazzaro Spallanzani, Scientific Hospital and Care Institutions, HIV/AIDS Unit, Rome, Italy.
  • National Institute for Infectious Diseases Lazzaro Spallanzani, Scientific Hospitaller and Care Institutions, Scientific Direction, Rome, Italy.

Förderung

  • Administration for Community Living
  • Ministero della Salute

Zitieren

APA

Vergori, A., Matusali, G., Lepri, A. C., Cimini, E., Fusto, M., Colavita, F., Gagliardini, R., Notari, S., Mazzotta, V., Mariotti, D., Cicalini, S., Girardi, E., Vaia, F., Maggi, F., Antinori, A., & HIV-VAC Study group (2023). Neutralizing activity and T-cell response after bivalent fifth dose of messenger RNA vaccine in people living with HIV. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2023.06.010

Vancouver

Vergori A, Matusali G, Lepri AC, Cimini E, Fusto M, Colavita F, et al. Neutralizing activity and T-cell response after bivalent fifth dose of messenger RNA vaccine in people living with HIV. International Journal of Infectious Diseases. 2023. doi:10.1016/j.ijid.2023.06.010

BibTeX
@article{Vergori2023,
  author = {Vergori, Alessandra and Matusali, Giulia and Lepri, Alessandro Cozzi and Cimini, Eleonora and Fusto, Marisa and Colavita, Francesca and Gagliardini, Roberta and Notari, Stefania and Mazzotta, Valentina and Mariotti, Davide and Cicalini, Stefania and Girardi, Enrico and Vaia, Francesco and Maggi, Fabrizio and Antinori, Andrea and HIV-VAC Study group, HIV-VAC Study group},
  title = {Neutralizing activity and T-cell response after bivalent fifth dose of messenger RNA vaccine in people living with HIV},
  journal = {International Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1016/j.ijid.2023.06.010}
}
Kostenlos starten →